GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » Debt-to-Asset

Paxman AB (FRA:B0F) Debt-to-Asset : 0.09 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB Debt-to-Asset?

Paxman AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €1.45 Mil. Paxman AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €0.11 Mil. Paxman AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was €18.30 Mil. Paxman AB's debt to asset for the quarter that ended in Sep. 2024 was 0.09.


Paxman AB Debt-to-Asset Historical Data

The historical data trend for Paxman AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB Debt-to-Asset Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.37 0.63 0.10 0.10 0.08

Paxman AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.09 0.07 0.09

Competitive Comparison of Paxman AB's Debt-to-Asset

For the Medical Devices subindustry, Paxman AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paxman AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Paxman AB's Debt-to-Asset falls into.



Paxman AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Paxman AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Paxman AB's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paxman AB  (FRA:B0F) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Paxman AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Paxman AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engaged in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB Headlines

No Headlines